Analgesic Efficacy of Local Anesthetic Transversus Abdominis Plane (TAP) Blocks in Abdominal Surgery
Efficacy of Local Anesthetic TAP Blocks in Providing Pain Relief Following Laparoscopic and Open Abdominal Surgery
2 other identifiers
interventional
206
1 country
4
Brief Summary
The aim of the study is to establish the efficacy of local anaesthetic TAP (transversus abdominis plane) blocks in providing pain relief in the first 24hrs following open or laparoscopic elective abdominal colorectal operations. TAP blocks involve the injection of local aesthetic (ropivicaine) into the transversus abdominis plane in the abdominal wall. This injection takes place after induction of anaesthesia, but before the commencement of surgery. TAP blocks have been proposed as a potential safer alternative to epidural anaesthesia. The blocks have been extensively used in the Hunter New England system over the last 18 months. As yet there is no clear evidence for there efficacy, hence the need for this trial. This trial would establish the efficacy of this practice. If the technique proves effective it could be widely used and provide a simpler method of managing post operative pain.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_1 pain
Started Apr 2008
Typical duration for phase_1 pain
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2008
CompletedFirst Submitted
Initial submission to the registry
May 20, 2008
CompletedFirst Posted
Study publicly available on registry
May 22, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2009
CompletedJune 3, 2010
June 1, 2010
1.7 years
May 20, 2008
June 2, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
mg/kg of morphine equivalent used by patients post operatively.
From operation until discharge.
Secondary Outcomes (2)
Lung Function (spirometry), including FVC, FEV1 and PEFR
24, 48 and 72 hours postoperatively
Visual Analogue Scale for pain at rest, deep breathing and coughing.
24, 48 and 72 hours postoperatively
Study Arms (2)
1
ACTIVE COMPARATOROpen Laparotomy Arm: All patients enrolled in the study who are undergoing elective open laparotomy surgery.
2
ACTIVE COMPARATORLaparoscopic Arm: All patients enrolled in the study who are undergoing elective laparoscopic abdominal surgery.
Interventions
Bilateral injection of local anaesthetic into the Transversus Abdominis plane, guided by ultrasound.
Eligibility Criteria
You may qualify if:
- All patients aged 18 and over undergoing elective open or laparoscopic colorectal surgery performed by the participating surgeons within the study period will be considered for the trial.
You may not qualify if:
- History of adverse reaction to Ropivicaine or similar drug.
- Inability or refusal to give consent
- Coagulopathic
- Severe renal impairment
- Aged \<18 years
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (4)
John Hunter Hospital
New Lambton, New South Wales, 2305, Australia
Newcastle Private Hospital
New Lambton, New South Wales, 2305, Australia
Private Medical Suites
New Lambton, New South Wales, 2305, Australia
Mater Misericordiae Hospital
Waratah, New South Wales, 2298, Australia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Brian Draganic, B.Med.,B.Med.Sci.(Hons),FRACS
Hunter Colorectal Research
- PRINCIPAL INVESTIGATOR
Stephen Smith, B.Med.,F.R.A.C.S.
Hunter Colorectal Research
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
May 20, 2008
First Posted
May 22, 2008
Study Start
April 1, 2008
Primary Completion
December 1, 2009
Study Completion
December 1, 2009
Last Updated
June 3, 2010
Record last verified: 2010-06